Lupin launches generic Ciprofloxacin in US market
The company had earlier received final approval for the product from the United States Food and Drug Administration (USFDA), it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cipro | Ciprofloxacin | Food and Drug Administration (FDA) | Pharmaceuticals